MS Treatments Episodes

Just a few weeks ago, life sciences company Abata Therapeutics came out of stealth mode, unveiling a $95 million dollar investment in a novel cell therapy to treat progressive MS. Joining me to talk about this potentially transformational treatment for progressive MS are the President and CEO of Abata Therapeutics, Samantha Singer, and Dr. Richard Ransohoff, one of the company's co-founders as well as its Chief Medical Officer. We'll also give you a sneak peek at a study that measured the impa...

Summertime traditionally means getting out of the house, enjoying outdoor activities, and being active. But if you're living with MS, outdoor activity and summertime temperatures can raise red flags when it comes to your day-to-day quality of life. My guest is Dr. Colin Lenington, an Occupational Therapist and Clinical Specialist at the VA Long Beach Healthcare System and we're talking about getting outside, staying safe, and keeping cool while you enjoy your summer activities. We're joining t...

Some people call them flares, some people call them exacerbations, and some people call them MS attacks. But all those terms refer to the very same thing -- an MS relapse. What does a relapse really mean in terms of disease progression? What's the difference between a relapse and a pseudo-relapse? How does pregnancy make you less likely to experience a relapse and then more likely to experience a relapse? Dr. Michelle Cameron is joining me to answer these questions and to share some advice on h...

As the United States begins to move past the pandemic and toward something much closer to life as we once knew it, I've received a lot of questions from members of the RealTalk MS listener community who are concerned about how their disease-modifying therapy may affect the efficacy of the COVID-19 vaccine, whether the authorized vaccines will protect them from variants, and whether they should continue wearing a mask, despite encouraging recommendations from the CDC. As Chair of the National MS...

When Pierluigi Montovani saw what was available to help his father rehabilitate his MS-related foot drop, he was motivated to invent something better. Pierluigi recruited a couple of friends and their efforts led to a breakthrough solution for foot drop that was declared the winner of the Lyfebulb and Bristol Myers Squibb Addressing Unmet Needs in MS: Innovation Challenge. Pierluigi joins me as my guest this week to discuss EvoWalk, his award-winning example of innovation in MS rehabilitation. ...

In today's special episode of RealTalk MS, Dr. Michael Kornberg is going to give us a glimpse into emerging research and the future of MS treatments. So, if you'd like to peer into the not-too-distant future for a preview of the new MS therapies that will be available to you, this is the conversation you're looking for. Dr. Kornberg is an Assistant Professor of Neurology at the Johns Hopkins University School of Medicine and, in addition to his clinical work, Dr. Kornberg's lab is focused on id...

With 200 million Americans having already received their COVID-19 vaccination, public health officials are warning that vaccine hesitancy is a growing challenge to our nation's ability to fully bounce back from the pandemic and resume something resembling the life we once knew. If what you're seeing and hearing about the COVID vaccines on social media or from well-meaning friends and family is making you nervous, my guest, Dr. Dorlan Kimbrough, is joining me to set the record straight. Dr. Kim...

Their website says that Destination Rehab takes an "innovative, out-of-the-box approach to physical therapy." This week, my guests are Sally McAllister and the founder of Destination Rehab, Dr. Carol-Ann Nelson. Sally is 70 years old and living with primary progressive MS. We're talking about how Sally's work with Dr. Nelson produced life-changing results. We're also talking about the first study that specifically measures the safety of the Pfizer-BioNtech COVID vaccine for people living with M...

MS affects almost 3 times as many women as men. Have you ever wondered why? When it comes to investigating sex differences in MS, my guest, Dr. Rhonda Voskuhl, has done more than just think about it. And her recent research may have uncovered an MS treatment for women undergoing menopause. Dr. Voskuhl is the President-elect of the International Organization for the Study of Sex Differences and the Director of the Multiple Sclerosis Program at UCLA. We're also talking about the potentially game...

More than half of all the people living with MS will develop problems with cognition. And while experiencing cognitive dysfunction can be challenging and frustrating, these kinds of changes can also be frightening. Joining me to talk about things you can do to better manage cognitive changes and preserve healthy cognition is neuroscientist and neuropsychologist, Dr. Victoria Leavitt. We're also talking about the encouraging results from a small clinical trial that tested stem cell therapy to t...